The hybrid CAP-Exo successfully suppressed the production of MMP-13 in chondrocytes, penetrated the deep region of the cartilage matrix in osteoarthritis rats, and attenuated the hydrolytic breakdown of the extracellular matrix proteins in the cartilage. This evidence concerns the gene MMP13 and osteoarthritis.